Tag: merck

August 11, 2021

Blockchain Market Update: H1 2021 in Review

What should investors know about the world of blockchain-powered technologies and cryptocurrencies in 2021?
June 9, 2021

5 Small Biotech ETFs

Want to invest in small biotech ETFs? INN profiles five examples that life science investors may want to look into.
February 11, 2021

10 Top Pharma Companies by Revenue

Here's a breakdown of the top pharma companies by revenue in 2019, according to information from research firm GlobalData.
September 28, 2020

What is In-Licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
February 27, 2020

Barclays Sees Upside in US Biopharma Industry

Barclays Capital has initiated coverage of the US biopharma space and will follow 16 companies in the market.
February 5, 2020

Merck Announces Q4 and Full-Year 2019 Financial Results

Merck reported quarterly sales at US$11.9 billion in Q4 in its financial results for the fourth quarter of 2019 and...
November 12, 2019

NewLink Genetics Receives European Commission Grant of Conditional Marketing Approval for V920

The European Commission has granted a conditional marketing authorization to ERVEBO, an investigational V920 Ebola Zaire vaccine.